Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results
2022 · Nature Medicine · 527 citations
https://doi.org/10.1038/s41591-022-01800-8
Z
Zhihao Lü
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
202
Papers
5.1K
Citations
33
h-index
82
i10-index
Zhihao Lü is an academic researcher from Nanjing Tech University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Gastric Cancer Management and Outcomes & Esophageal Cancer Research and Treatment. The author has an h-index of 33, co-authored 172 publications.
ORCID: 0000-0001-9091-4946Papers by this author
worksHepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features
2019 · Gastric Cancer · 104 citations
https://doi.org/10.1007/s10120-019-00965-5
Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer
2016 · British Journal of Cancer · 100 citations
https://doi.org/10.1038/bjc.2015.417
Circulating tumor <scp>DNA</scp> functions as an alternative for tissue to overcome tumor heterogeneity in advanced gastric cancer
2017 · Cancer Science · 69 citations
https://doi.org/10.1111/cas.13314
Disitamab vedotin (RC48) plus toripalimab for HER2-expressing advanced gastric or gastroesophageal junction and other solid tumours: a multicentre, open label, dose escalation and expansion phase 1 trial
2024 · EClinicalMedicine · 58 citations
https://doi.org/10.1016/j.eclinm.2023.102415
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer
2018 · Gastric Cancer · 56 citations
https://doi.org/10.1007/s10120-018-0809-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat